Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Erick Figueiredo Saldanha"'
Autor:
Huaqi Li, Melanie Lynn Powis, Erick Figueiredo Saldanha, Rachel Simoes Riechelmann, Abed Baiad, Felicia Peterson Cavalher, Kevin Chen, Maria Rita Silva Costa, Saidah Hack, Zuhal Mohmand, Peter Nakhla, Maria Fernanda Evangelista Simões, Monika K. Krzyzanowska
Publikováno v:
Journal of Clinical Oncology. 40:28-28
28 Background: The reorganization of cancer care delivery during the COVID pandemic had the potential to catalyze improvement in CWR adherence by reducing provision of low value care to minimize in-person visits and mitigate potential issues with sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0582f744b54ef3b8b87a639b7fb85c8
https://doi.org/10.1200/jco.2022.40.28_suppl.028
https://doi.org/10.1200/jco.2022.40.28_suppl.028
Autor:
Rafael Lima Viana, M.F. Simões, Fernando Augusto Batista Campos, Vladmir Cláudio Cordeiro de Lima, Luciana de Moura Leite, Bruna Raphaeli Silva Mattos, Paula Tavares Guimarães, Noam Pondé, Debora Maciel Santana, Daniella Dias Silva Sá, F. Rocha, Sinara Figueiredo Silva, Erick Figueiredo Saldanha, Solange Moraes Sanches, Marcelle Goldner Cesca, Rafaela Pirolli, Camilla Albina Zanco Fogassa, Monique Celeste Tavares, Simone Klog Loose
Purpose: Recently, phase I studies with novel antibody drug conjugates targeting HER2 suggested benefit in HER2-low patients – defined as immunohistochemistry(IHC) +1 or +2 FISH/ISH non-amplified, with advanced breast cancer(BC). Data on the progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98fd26dd52572004e785fb728f0e6d0
https://doi.org/10.21203/rs.3.rs-420934/v1
https://doi.org/10.21203/rs.3.rs-420934/v1
